Cure8 research brief
This identifies a metabolism-related epithelial gene (PCK1) linked to inflammation in UC and suggests acetyl‑L‑carnitine can partially reverse those changes in cell and mouse models—information that could guide future biomarker or treatment research.
Researchers studying IBD metabolism, epithelial biology, biomarkers, or preclinical drug discovery; clinicians interested in mechanistic research; patients following experimental metabolic therapies (research context).
This paper used integrative analyses of public bulk transcriptomic datasets plus single-cell and spatial transcriptomics to identify metabolic genes linked to ulcerative colitis (UC). PCK1 (phosphoenolpyruvate carboxykinase 1) emerged as a top candidate: it was downregulated in UC and enriched in epithelial cells.
Laboratory experiments showed that reducing PCK1 increased inflammatory responses in cultured intestinal epithelial cells and that pharmacologic inhibition of PCK1 worsened inflammation in a mouse colitis model.
Treatment with acetyl‑L‑carnitine (ALC) partially restored PCK1 expression and reduced inflammatory measures, potentially involving AMPK pathway activation. The findings are exploratory and combine computational analyses with cell- and mouse-based experiments rather than clinical testing.
The study supports PCK1 as a metabolism-linked epithelial regulator in UC and suggests ALC may modulate related pathways in preclinical models.
Structured-content depth is an abstract from the journal; this report combines bioinformatic analyses with in vitro and mouse experiments. Results are preclinical and do not demonstrate clinical benefit in people. ALC effects here are shown in models, not human trials.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Phosphatidylcholines are implicated in IBD biology; identifying a gene that regulates PC metabolism could point to new mechanistic targets. If PRKAB1 modulates epithelial lipid metabolism relevant to inflammation, it may...
The study synthesizes many stool metagenomes to find consistent microbial species, functional pathways, and strain-level differences linked to IBD and to distinctions between Crohn’s disease and ulcerative...
The review highlights how microbial metabolites, epigenetic regulation, and mitochondrial metabolism interact to shape inflammation and barrier function in IBD. Understanding these links could help identify new...
